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Summary
Objective: To examine associations of maternal gestational diabetes mellitus (GDM)
with offspring cardiovascular biomarkers from late childhood through adolescence.
Methods: We used mixed effects linear regression models to examine associations of
maternal GDM (n = 92 cases of 597) with average offspring levels of serum lipids
(total cholesterol, high-density lipoprotein [HDL], low-density lipoprotein [LDL], and
triglycerides) and systolic blood pressure (SBP) across two research visits spanning
approximately 10.6 and 16.9 years of age. In sex-stratified analysis, we evaluated the
impact of adjustment for sociodemographic characteristics, pubertal status, physical
activity and total energy intake, maternal body mass index (BMI), GDM treatment,
and child's BMI.
Results: After adjusting for child's age, pubertal status, race/ethnicity, and maternal
education and smoking, GDM exposure was associated with higher total (0.38 [95%
CI, 0.16-0.61] mmol/L) and LDL cholesterol (0.34 [95% CI, 0.14-0.53] mmol/L) in
girls. These estimates were robust to adjustment for lifestyle characteristics and
maternal BMI but were attenuated after accounting for GDM treatment with no
appreciable change following further adjustment for current BMI. In boys, maternal
GDM corresponded with 4.50 (1.90-7.10) mmHg higher SBP. This association per-
sisted after accounting for sociodemographic/lifestyle characteristics, maternal BMI,
and GDM treatment but was attenuated after adjusting for current BMI.
Conclusions: Maternal GDM is related to offspring lipid profile and SBP in a sex-
specific manner.
K E YWORD S
adolescence, blood pressure, gestational diabetes mellitus, longitudinal, low-density
lipoprotein, total cholesterol
1 | INTRODUCTION
In his famous 1980 lecture, “Of Pregnancy and Progeny,” Norbert
Freinkel called gestational diabetes mellitus (GDM) a “teratogen” that
leads to higher birthweight and congenital defects.1 A number of
Abbreviations: BMI, body mass index; HDL, high-density lipoprotein; LDL, low-density
lipoprotein; METs, metabolic equivalents; MVPA, moderate to vigorous physical activity;
SBP, systolic blood pressure.
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epidemiological studies have since noted detrimental effects of mater-
nal GDM on offspring fat distribution starting at birth2-6 and on
glycaemic regulation (insulin resistance, impaired glucose tolerance,
low insulin secretion, and reciprocally altered adipokines6-9) by age
6 years. Fewer studies have evaluated associations of in utero expo-
sure to GDM with biomarkers of cardiovascular risk, which are impor-
tant to consider given the interrelations among cardiovascular and
metabolic biomarkers, and the persistent burden of cardiovascular dis-
ease worldwide10—a nonnegligible proportion of which may be traced
back to the gestational metabolic milieu.11 The majority of publica-
tions that have assessed the relation between maternal GDM and car-
diovascular health in offspring focused on the adolescent life stage
(although one study was conducted in children aged 3 years12) and
identified associations with higher offspring blood pressure6,12-16 and
an adverse lipid profile.16 Many of these studies were able to establish
associations independent of offspring adiposity,6,12,14 suggesting a
unique influence of maternal GDM on in utero “programming” of
cardiovascular risk.
In this prospective study of greater than 500 multi-ethnic youth,
we test the hypothesis that in utero exposure to maternal GDM with
biomarkers of cardiovascular risk in offspring from late childhood
through adolescence in the Exploring Perinatal Outcomes in Children
(EPOCH) cohort. The biomarkers of interest included serum lipid pro-
file (total cholesterol, triglycerides, high-density lipoprotein [HDL],
and low-density lipoprotein [LDL]) and blood pressure, which track
from childhood/adolescence into adulthood and are independent pre-
dictors of future cardiovascular and metabolic disease risk.17-21 This
work extends current knowledge in this area of research in two key
ways. First, we investigate associations of maternal GDM with bio-
markers of cardiovascular risk longitudinally across a period that spans
the adolescent transition via a repeated measures approach. Given
that multiple measurements of health are more informative than sin-
gle measurements, our analytical strategy is an improvement upon
that of current literature, which has focused on evaluating associa-
tions of early life exposures with health outcomes at a single point in
time later in life (including an earlier study in EPOCH that focused on
data at the first research visit only6). Second, in all models, we con-
sider sex-specific associations given documented differences in fetal
(as well as later-life2) response to in utero exposures22-24 and sex dif-
ferences in metabolism during the adolescent life stage.25
2 | METHODS
2.1 | Study population
Study participants were from a historical prospective cohort of youth
whose mothers were members of the Kaiser Permanente of Colorado
(KPCO) Health plan. Details on eligibility and recruitment are publi-
shed.3 Of the original 604 participants enrolled, we excluded from the
present analysis children of seven women with type 1 diabetes. The
analytic sample comprised 597 youth at the first research visit and
410 at the second one with information on at least one cardiovascular
risk factor of interest. The Colorado Multiple Institutional Review
Board approved this study.
2.2 | Exposure
All pregnant women at KPCO are routinely screened for GDM at
24 to 28 weeks using the standard two-step protocol.26 A total of
92 women in the sample had a GDM diagnosis.
2.3 | Outcomes
Using blood collected after an 8-hour fast, total cholesterol, HDL, and
triglycerides were assayed on the Olympus AU400 advanced chemis-
try analyser system. We calculated LDL as (total cholesterol) − (HDL
cholesterol) − (triglycerides/5). Research assistants measured partici-
pants' blood pressure twice in the sitting position using an oscillo-
metric monitor (Dinamap ProCare V100). We used the average of the
two values in the analysis and focused on systolic blood pressure
(SBP) rather than diastolic blood pressure because it is more accu-
rately measured in children and is a stronger determinant of future
health outcomes.27
2.4 | Covariates
2.4.1 | Perinatal and delivery characteristics
We calculated maternal pre-pregnancy body mass index (BMI; kg/m2)
using clinically recorded pre-pregnancy weight from KPCO medical
records and measured height at the first research visit. The medical
record also provided information on pregnancy complications such as
preeclampsia and birthweight (g) as well as delivery characteristics like
gestational age at delivery (weeks) for the index birth.
At T1, the women reported on smoking habits during pregnancy,
education level at time of birth, and total gestational weight gain (lbs)
via a self-administered questionnaire. In the analysis, we categorized
maternal education as a three-level variable (“<high school,” “high
school diploma or equivalent,” and “>high school”) and smoking as a
dichotomous variable (smoked while pregnant with index child, yes vs
no). At this visit, the mothers also filled out a questionnaire regarding
any treatment they received for GDM. GDM treatment was catego-
rized as diet and/or exercise only, diet and/or exercise with insulin,
and insulin only. Because of the small sample size for insulin only
treatment (n = 5), we combined this category with diet and/or exer-
cise when using this variable as a covariate in the analysis.
2.4.2 | Participant characteristics
We calculated participants' age as the difference between date of
each research visit and delivery date. At both visits, we measured the
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participants' weight on a digital scale to the nearest 0.1 kg and mea-
sured height (cm) via a calibrated stadiometer to the nearest 0.1 m.
We calculated BMI and standardized it according to the age- and sex-
specific World Health Organization (WHO) growth reference.28 Par-
ticipants self-reported on their race/ethnicity as non-Hispanic White,
non-Hispanic Black, Hispanic, and non-Hispanic other. Participants
reported their pubertal development based on diagrams of the Tanner
stages. We based pubertal status on pubic hair development in boys
and breast development in girls. For each characteristic, we classified
a child as pre-pubertal (Tanner stage = 1) or pubertal (Tanner stag-
e ≥ 2). We obtained information on the participants' physical activity
levels using the 3-Day Physical Activity Recall (3DPAR) Question-
naire.29 Using 3DPAR, we derived average energy expenditure (meta-
bolic equivalents; METs) and mean number of moderate- to-vigorous
30-minute blocks of physical activity (METs) over the 3-day period. At
both visits, participants completed the Block Kid's Food Frequency
Questionnaire (FFQ).30 We used these data in conjunction with the
USDA Food Composition Database to estimate total energy intake
(kcals/day).
2.5 | Data analysis
First, we assessed bivariate associations of in utero GDM exposure
with maternal, perinatal, and offspring characteristics to identify poten-
tial confounders. This step, in conjunction with our a priori knowledge
of determinants of cardiovascular health in youth, informed our multi-
variable analysis.
Next, we examined associations of GDM exposure with cardio-
vascular biomarkers from late childhood through adolescence using a
mixed effects linear regression model wherein the outcome of interest
was repeated measurements of each biomarker. The explanatory vari-
ables included longitudinal assessments of age at each research visit, a
random effect for individual ID to account for the repeated outcomes,
and an unstructured covariance matrix. We have previously used this
approach as a way to characterize growth trajectories from longitudi-
nal assessments of anthropometric data.31-33 A key advantage of this
approach (as opposed to conventional linear regression to examine
associations of an exposure with the outcome of interest at separate
time points, or with change in the outcome between specific time
points) is that it does not require that all participants have the same
number of measurements assessed at exactly the same time. In this
study, the participants may have a maximum of two measurements
for each biomarker, but if a participant has biomarker data at one visit
only, their information still contributes to estimation of standard
errors. This approach most efficiently leverages our longitudinal data,
both from an analytical standpoint and from the perspective of inter-
preting the biological relevance of results given that multiple assess-
ments of health are likely more meaningful than single evaluations.
Using this approach, the estimate of interest (β for GDM exposure) is
interpreted as the association of GDM with average levels of a bio-
marker over the 6 years of follow-up. A key assumption of using
mixed effects models to generate population-level estimates is
homogeneity of associations in the face of variation in the age distri-
bution of the population. Thus, we tested for birth cohort effects by
including an interaction term between age at first research visit and
GDM exposure; the interaction terms provided no evidence of birth
cohort effects.
In multivariable analysis, we evaluated the impact of covariate
adjustment on the β and 95% confidence interval (CI) for maternal
GDM. Covariates for model 1 included longitudinal assessments of
the child's age in years and pubertal status (ie, up to two data points
for each variable per child, measured at the same time as the cardio-
vascular outcomes), as well as race/ethnicity, maternal education at
the time of birth, and smoking habits during pregnancy. Model 2 fur-
ther accounted for longitudinal assessments of mean energy expendi-
ture and total energy intake. Model 3 included model 1 covariates
plus maternal pre-pregnancy BMI, given that a woman's pre-gravid
weight status likely influences offspring health through shared path-
ways with hyperglycaemia. Model 4 included model 1 covariates plus
GDM treatment to account for variability in maternal hyperglycaemia
following a diagnosis of GDM. In Model 5, we adjusted for model
4 covariates plus the child's current BMI to assess for an independent
association of maternal GDM (while adjusting for treatment) with off-
spring cardiovascular biomarkers independent of offspring adiposity.
In all models, we tested for interactions with sex (which tests for
a difference in association of GDM with cardiovascular outcomes for
girls vs boys), pubertal status at the first visit (which tests for a differ-
ence in association of GDM with cardiovascular outcomes by pubertal
status), and repeated measurements of age across the two research
visit (which tests for differences in slopes of biomarker trajectories
over time for GDM exposed vs unexposed). We considered
P interaction <.05 as the threshold for a need to conduct stratified
analysis. As expected, we found evidence of effect modification of
association between GDM and cardiovascular risk factors by sex, so
we conducted all models separately for boys and girls. We did not
observe evidence of effect modification by the other above-
mentioned variables.
2.5.1 | Sensitivity analyses
In addition to the main analysis, we carried out some sensitivity ana-
lyses. First, because height is a strong determinant of BP in children
and adolescents34 and because clinical assessments of paediatric
blood pressure are based on age-, sex-, and height-specific values,35
we reran models for blood pressure with SBP z score as the outcome.
Results for SBP and SBP z score were similar, so we focus on interpre-
tation of SBP in mmHg for interpretability. Second, given the co-
occurrence of GDM and preeclampsia,36 we reran all models after
excluding 27 mother-offspring pairs affected by preeclampsia. Exclu-
sion of these individuals did not appreciably change our findings; thus,
we included these participants in our analysis. Finally, we assessed the
impact of adjustment for birthweight and gestational age at delivery,
two mediating perinatal characteristics that are determinants of long-
term cardiovascular health.37-39 Adjusting for these variables did not
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change the direction, magnitude, or precision of the results, so we did
not include them in the final models.
We carried out all analyses using Statistical Analyses System soft-
ware (version 9.3; SAS Institute Inc., Cary, NC).
3 | RESULTS
Mean ± SD age of participants at the first research visit was 10.4
± 1.5 years (range: 6.0-13.9 years) and 16.7 ± 1.2 years (range:
12.6-19.6 years) at the second research visit, with an approximate
follow-up time of 6 years. Fifty percent of the participants were
female, and 48.1% (n = 287) were non-Hispanic White. Approximately
15% (n = 92) of participants were exposed to GDM in utero. Table 1
shows descriptive characteristics for mother-child dyads stratified by
GDM exposure, and Table S1 shows the same characteristics strati-
fied by sex. Associations of GDM exposure status with background
characteristics were similar across sex, although we noted that a
higher proportion of exposed girls were post-pubertal at the first visit
(53.5% post-pubertal) then exposed boys (24.5% post-pubertal).
TABLE 1 Bivariate associations of in utero GDM exposure with background characteristics of 597 EPOCH participants
GDM exposed Unexposed
P value*n = 92 n = 505
Maternal characteristics
Maternal pre-pregnancy BMI (kg/m2) 27.8 ± 6.3 25.4 ± 5.8 .001
Maternal education level .50
<High school 5.4% 3.4%
High school or equivalent 15.2% 18.4%
>High school 79.4% 78.2%
Mother smoked during pregnancy 14.1% 7.3% .03
GDM treatment
Diet and/or exercise 66.3% –






Female 46.70% 50.90% .46
Race/ethnicity .02
Non-Hispanic White 63.0% 45.4%
Hispanic 28.3% 40.0%
Non-Hispanic Black 4.4% 8.5%
Non-Hispanic other 4.4% 6.1%
Anthropometry and lifestyle at T1
BMI z score 0.37 ± 1.33 0.23 ± 1.21 .32
Post-pubertal (Tanner stage ≥2) 57.10% 37.40% .003
Mean energy expenditure (METs) 1.85 ± 0.32 1.90 ± 0.31 .13
Mean moderate-to-vigorous physical activity (METs) 4.15 ± 2.94 4.26 ± 2.80 .74
Total energy intake (kcal/per day) 1744 ± 458 1798 ± 562 .38
Anthropometry and lifestyle at T2
BMI z score 0.54 ± 1.05 0.38 ± 1.13 .26
Post-pubertal (Tanner stage ≥2) 100.00% 100.00% –
Mean energy expenditure (METs) 1.85 ± 0.27 1.91 ± 0.32 .12
Mean moderate-to-vigorous physical activity (METs) 4.81 ± 4.48 4.70 ± 3.77 .82
Total energy intake (kcal/d) 1683 ± 767 1653 ± 725 .76
Abbreviations: BMI, body mass index; EPOCH, Exploring Perinatal Outcomes in Children; GDM, gestational diabetes mellitus; MET, metabolic equivalent.
*From an independent t test for continuous variables; from a Pearson chi-squared test for categorical variables.
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Table 2 shows mean ± SD for the cardiovascular risk biomarkers
of interest at each visit for all children and separately by sex,
respectively.
Table 3 displays sex-specific associations of GDM exposure with
cardiovascular risk factors over the entire age-range of study partici-
pants from both research visits. We interpret these results as the
association of in utero GDM exposure on average levels of each car-
diovascular risk factor across the two research visits (rather than aver-
age trajectories of change per year) as we did not find a significant
interaction between GDM exposure and time, which suggests a con-
sistent influence of GDM exposure on these health outcomes. After
accounting for key confounders in model 1, girls who were exposed
to GDM in utero had 0.38 (95% CI, 0.16-0.61) mmol/L and 0.34 (95%
CI, 0.14-0.53) mmol/L higher total cholesterol and LDL, respectively,
than their unexposed counterparts. This association was robust to
adjustment for physical activity and total energy intake (model 2) and
maternal pre-pregnancy BMI (model 3). However, adjustment for
GDM treatment in model 4 attenuated both estimates to approxi-
mately 2/3 the magnitude, with the lower CI crossing the null
(Table 3). Further adjustment for the offspring's current BMI z score in
model 5 did not change the estimates.
In boys, GDM exposure corresponded with 4.50 (95% CI,
1.90-7.10) mmHg higher SBP from late childhood through adolescence
TABLE 2 Descriptive statistics for cardiovascular risk factors of
597 EPOCH participants at two research visits (ages 6-14 and
12-19 y)
Visit 1 Visit 2
n = 300 n = 206
Girls
Age (years) 10.4 ± 1.4 16.7 ± 1.2
Cholesterol (mmol/L) 4.1 ± 0.7 3.8 ± 0.8
HDL (mmol/L) 1.3 ± 0.3 1.2 ± 0.3
LDL (mmol/L) 2.3 ± 0.6 2.1 ± 0.6
Triglycerides (mmol/L) 1.1 ± 0.5 1.0 ± 0.6
SBP (mmHg) 102.1 ± 9.6 112.0 ± 9.7
Boys n = 297 n = 204
Age (years) 10.5 ± 1.5 16.6 ± 1.1
Cholesterol (mmol/L) 4.1 ± 0.8 3.6 ± 0.6
HDL (mmol/L) 1.3 ± 0.3 1.1 ± 0.2
LDL (mmol/L) 2.4 ± 0.7 2.0 ± 0.5
Triglycerides (mmol/L) 1.0 ± 0.4 1.0 ± 0.4
SBP (mmHg) 103.8 ± 10.3 119.4 ± 10.6
Abbreviations: EPOCH, Exploring Perinatal Outcomes in Children; HDL,
high-density lipoprotein; LDL, low-density lipoprotein; SBP, systolic blood
pressure.
TABLE 3 Associations of in utero exposure to GDM with CV traits across in 597 EPOCH participants across T1 (age 6-14 y) and T2 (age
12-19 y)
Model 1 Model 2 Model 3 Model 4 Model 5
n = 300 n = 298 n = 207 n = 300 n = 300
Girls (n = 300)
Cholesterol (mmol/L) 0.38 (0.16-0.61) 0.39 (0.16-0.62) 0.34 (0.07-0.61) 0.24 (−0.08 to 0.57) 0.25 (−0.08 to 0.57)
HDL (mmol/L) 0.01 (−0.06 to 0.08) 0.01 (−0.06 to 0.08) −0.05 (−0.13 to 0.02) −0.01 (−0.12 to 0.10) −0.02 (−0.13 to 0.10)
LDL (mmol/L) 0.34 (0.14-0.53) 0.36 (0.16-0.55) 0.33 (0.10-0.55) 0.21 (−0.10 to 0.51) 0.21 (−0.10 to 0.52)
Triglycerides (mmol/L) 0.11 (−0.07 to 0.29) 0.08 (−0.10 to 0.26) 0.16 (−0.04 to 0.35) 0.10 (−0.12 to 0.31) 0.11 (−0.10 to 0.32)
SBP (mmHg) 0.93 (−1.16 to 3.03) 0.81 (−1.30 to 2.93) −1.52 (−4.04 to 0.99) −1.75 (−6.32 to 2.83) −1.10 (−4.94 to 2.74)
n = 296 n = 293 n = 230 n = 297 n = 297
Boys (n = 297)
Cholesterol (mmol/L) −0.06 (−0.28 to 0.16) −0.06 (−0.29 to 0.16) 0.03 (−0.22 to 0.27) 0.15 (−0.40 to 0.70) 0.09 (−0.47 to 0.65)
HDL (mmol/L) −0.06 (−0.14 to 0.02) −0.06 (−0.14 to 0.02) −0.11 (−0.20 to −0.02) 0.13 (−0.01 to 0.27) 0.14 (−0.01 to 0.28)
LDL (mmol/L) 0.01 (−0.18 to 0.19) −0.02 (−0.21 to 0.17) 0.10 (−0.11 to 0.30) 0.08 (−0.34 to 0.51) 0.05 (−0.39 to 0.48)
Triglycerides (mmol/L) 0.04 (−0.07 to 0.15) 0.06 (−0.06 to 0.17) 0.09 (−0.03 to 0.21) −0.12 (−0.54 to 0.30) −0.18 (−0.59 to 0.22)
SBP (mmHg) 4.50 (1.90-7.10) 4.56 (2.02-7.10) 3.11 (0.28-5.94) 6.27 (0.18-12.36) 4.60 (−1.82 to 11.02)
Bold face font indicates statistical significance at α = 0.05.
Notes: Estimates are from a linear mixed effects model where the dependent variable is repeated measurements of the CVD traits across T1 and T2, and
the predictors include GDM (yes vs no), covariates, and a random effect for individual intercept.
Model 1: Adjusted for child's age (years), pubertal status (pre vs post-pubertal), race/ethnicity (non-Hispanic White, Hispanic, non-Hispanic Black, and
non-Hispanic other), maternal smoking habits during pregnancy (yes vs no) and education level at time of birth (<high school, high school, and >high
school).
Model 2: Model 1 + physical activity levels (average energy expenditure; METs) and total energy intake (kcals).
Model 3: Model 1 + maternal pre-pregnancy BMI.
Model 4: Model 1 + GDM treatment (diet/exercise only vs none, diet/exercise with insulin vs none).
Model 5: Model 4 + child's BMI z score.
Abbreviations: CV, cardiovascular; EPOCH, Exploring Perinatal Outcomes in Children; GDM, gestational diabetes mellitus; HDL, high-density lipoprotein;
LDL, low-density lipoprotein; SBP, systolic blood pressure.
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(Table 3, model 1). Accounting for physical activity and total energy
intake in model 2 did not change this estimate, although adjusting for
maternal pre-pregnancy BMI in model 3 attenuated the estimate by
approximately 30%. In model 4, adjustment for GDM treatment aug-
mented the association to 6.27 (95% CI, 0.18-12.36) mmHg for
exposed vs unexposed males. However, additional adjustment for the
offspring's current BMI z score attenuated the estimate such that the
magnitude was similar to those detected in models 1 and 2, and the
lower CI crossed the null (4.60 [95% CI, −1.82 to 11.02] mmHg). We
also noted that GDM exposure was associated with 0.11 (95% CI,
0.02-0.20) mmol/L lower HDL in boys, although the 95% CI included
the null for all models except Model 3.
Table S2 presents estimates of mean ± SE for the cardiovascular
risk factors with respect to GDM exposure after confounder adjust-
ment (model 1). We provide graphical depictions of these results in
Figure 1 (lipid profile) and Figure 2 (blood pressure).
Table S3 shows the same set of models as in Table 3 for sex-,
age-, and height-specific blood pressure z scores. The results from
analyses of z scores are similar to those of blood pressure in mmHg,
indicating no concern regarding residual confounding by age or height
in our primary analysis.
4 | DISCUSSION
In this prospective study of 597 multi-ethnic youth in Colorado, we
found sex-specific associations of in utero exposure to GDM with
lipid profile and blood pressure in offspring from late childhood
through adolescence. In girls, GDM was associated with higher total
cholesterol and LDL. In boys, GDM corresponded with consistently
higher SBP. These associations were consistent across the age-range
studied and did not change over time.
4.1 | Girls
In utero exposure to GDM corresponded with an average of
0.38 mmol/L (6.8 mg/dL) higher total cholesterol, and 0.34 mmol/L
F IGURE 1 Mean ± SE for lipid profile components among GDM-exposed vs unexposed EPOCH participants. Estimates are adjusted for
child's age (years), pubertal status (pre- vs post-pubertal), race/ethnicity (non-Hispanic White, Hispanic, non-Hispanic Black, and non-Hispanic
other), maternal smoking habits during pregnancy (yes vs no), and education level at time of birth (<high school, high school, and >high school).
*Statistically significant difference at α = .05. EPOCH, Exploring Perinatal Outcomes in Children; GDM, gestational diabetes mellitus; HDL, high-
density lipoprotein; LDL, low-density lipoprotein
F IGURE 2 Mean ± SE for SBP among GDM-exposed vs
unexposed EPOCH participants. Estimates are adjusted for child's age
(years), pubertal status (pre- vs post-pubertal), race/ethnicity (non-
Hispanic White, Hispanic, non-Hispanic Black, and non-Hispanic
other), maternal smoking habits during pregnancy (yes vs no) and
education level at time of birth (<high school, high school, and >high
school). *Statistically significant difference at α = .05. EPOCH,
Exploring Perinatal Outcomes in Children; GDM, gestational diabetes
mellitus; HDL, high-density lipoprotein; LDL, low-density lipoprotein;
SBP, systolic blood pressure
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(6.1 mg/dL) higher LDL cholesterol levels. These findings are compara-
ble with those of an analysis of 96 male and female Polish youth aged
7 to 16 years wherein Wilk et al40 detected unadjusted differences of
19.0 and 14.2 mg/dL higher total and LDL cholesterol, respectively,
among GDM-exposed (n = 50) vs unexposed participants (n = 46). In a
recent study of greater than 1000 boys and girls in the Danish
National Birth Cohort, Grunnet et al reported higher serum triglycer-
ides (5% [95% CI, 1-10%]) and lower HDL (−0.07 [95% CI, −0.11 to
−0.02] mmol/L), as well as marginally higher LDL (0.06 [95% CI, −0.01
to 0.14] mmol/L) at 12 years of age among GDM-exposed youth.16
However, these associations became null after adjusting for maternal
and child BMI.
In the present analysis, the influence of maternal GDM on the
above offspring cardiovascular risk factors remained apparent after
accounting for offspring characteristics known to impact lipid profile,
including pubertal status, physical activity, and energy intake, as well
as maternal pre-pregnancy BMI, a proxy for maternal adiposity that is
hypothesized to account for a portion of variability in the relationship
between maternal hyperglycaemia and offspring health. However,
accounting for GDM treatment attenuated the estimates for choles-
terol and LDL towards the null, thereby providing support for a spe-
cific effect of maternal hyperglycaemia on these cardiovascular traits.
In other words, if removing variability in maternal hyperglycaemia dur-
ing gestation by adjusting for GDM treatment in the analysis resulted
in smaller and nonsignificant effect estimates for maternal GDM, then
maternal hyperglycaemia is likely a determinant of the offspring health
outcomes.
Our finding that exposure to maternal GDM was associated with
an adverse lipid profile that is likely related to the occurrence of
perturbed maternal lipid metabolism in the context of gestational
hyperglycaemia,41 which in turn, may affect offspring lipid metabo-
lism.42 Mechanistic pathways are difficult to disentangle in humans,
but animal models indicate an impact of maternal hyperglycaemia on
hepatic lipid content and metabolism through oxidative stress and
inflammatory pathways.43 Although we adjusted for pubertal status in
multivariable analyses, the female-specific nature of the relationship
between exposure to maternal GDM and offspring lipid profile may
be related to unmeasured confounding by tempo of sexual maturation
(which exists on a spectrum that is likely not wholly captured by dis-
crete Tanner staging) given recent findings that GDM-exposed girls
undergo puberty earlier than their male counterparts. Earlier puberty
may in turn translate to more rapid increases in total cholesterol and
LDL.44
4.2 | Boys
Boys who were exposed to GDM in utero had approximately 5 mmHg
higher SBP than their unexposed counterparts. This relationship
remained apparent after accounting for sociodemographic and life-
style characteristics during follow-up but was modestly attenuated
after accounting for maternal pre-pregnancy BMI and current BMI.
Interestingly, adjustment for GDM treatment did not attenuate the
estimate, but rather, slightly increased the magnitude of effect of
maternal GDM from approximately 5 mmHg (models 1 and 2) to
approximately 6 mmHg higher SBP for GDM-exposed vs unexposed
boys (model 4). This indicates the existence of mechanisms other than
hyperglycaemia linking in utero GDM exposure to offspring blood
pressure. Indeed, when we further adjusted for the offspring's current
BMI z score (in addition to GDM treatment), the estimate for maternal
GDM in relation to SBP was approximately 5 mmHg and attenuated
to nonsignificance, suggesting that the relationship between maternal
hyperglycaemia and offspring SBP is mediated by the offspring
adiposity.
In a previous study conducted in this cohort that examined conse-
quences of maternal GDM on adiposity and cardiometabolic bio-
markers at the first visit, West et al6 detected a marginally significant
2 mmHg higher SBP between GDM-exposed and unexposed partici-
pants at 6 to 13 years. At this time, the investigators reported no dif-
ferences in the relationship between GDM and health outcomes by
sex and adjustment for maternal and child BMI attenuated the associ-
ations to the null. Similarly, in an investigation of 1238 children in the
Project Viva cohort, Wright et al12 found that GDM exposure cor-
responded with 3.2 mmHg higher SBP at 3 years of age after
adjusting for key covariates including for maternal pre-pregnancy
BMI. As with the study of West et al, further adjustment for the chi-
ld's current BMI markedly attenuated the estimate.
In addition to investigations that focused exclusively on GDM,
smaller studies have explored offspring cardiovascular consequences
of exposure to maternal diabetes during pregnancy based on a combi-
nation of pre-existing diabetes (type 1 or type 2) and GDM with off-
spring blood pressure. Cho et al15 noted 8 mmHg higher SBP
(P < .001) in a multi-ethnic population of 99 offspring aged 10 to
16 years, as compared with 80 unexposed counterparts after control-
ling for height, weight, sex, age, and pubertal status. Similarly, Rostand
et al13 reported 8 mmHg (P < .05) higher SBP among Black and White
children born to diabetic mothers as compared with those of
nondiabetic mothers (n = 10 diabetic vs 252 nondiabetic) after
accounting for sex, child's height, and maternal socio-economic factors.
Finally, in the Pima Indian Study, Bunt et al14 investigated associations
of maternal diabetes with offspring cardiovascular traits after account-
ing for % fat mass and sex and detected 11 mmHg higher SBP among
22 Pima Indian children aged 7 to 11 years exposed to diabetes in
utero, as compared with 20 offspring of nondiabetic women. Yet again,
these studies did not assess the impact of any treatments or interven-
tions to address hyperglycaemia during pregnancy.
Taken together, the current body of evidence suggestions that
maternal GDM is associated with higher blood pressure in offspring.
While the underlying physiological mechanisms are not known, our
data and those of others12 suggest that this relationship may be medi-
ated by excess adiposity given the established influence of maternal
hyperglycaemia on offspring fat mass at birth and beyond.2-6 Animal
studies also suggest the possibility of a direct effect of hyper-
glycaemia on kidney structure and function,45 which can affect blood
pressure. While this hypothesis has not specifically been tested in
humans, a study in the Pima Indians found that exposure to maternal
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diabetes corresponded with nearly four times higher urinary albumin
excretion in the offspring, pointing towards the capacity of maternal
diabetes to affect fetal nephron development.46 Another possible
mechanism linking maternal GDM to an adverse lipid profile involves
the co-occurrence of maternal dyslipidaemia, which may influence off-
spring blood pressure through other mechanisms.15 The fact that we
detected associations of GDM with SBP in boys but not girls may be
related to the more rapid increase and greater variability in SBP from
late childhood through adolescence in males than females.25
4.2.1 | Strengths and limitations
Our study had several strengths. First, we were able to examine long-
term consequences of exposure to maternal GDM on offspring car-
diovascular risk factors across the adolescent transition, a sensitive
period for development of cardiometabolic disease.47 Second, rich
covariate data enabled us to adjust for variables that may confound or
mediate associations of interest. Third, our longitudinal modelling
strategy appropriately accounted for correlations among repeated
assessments of cardiovascular risk factors and efficiently leveraged
the outcome data across two study visits spanning approximately
6 years of follow-up.
However, this study is not without limitations. A weakness of this
study is the fact that we only had access to medical record data that
provided information on GDM diagnosis, thereby precluding our abil-
ity to explore associations of the in utero glycaemic milieu at a finer
resolution. A second limitation is the slightly decreasing sample sizes
in multivariable models because of missing data for covariates,
although the subsamples did not differ with respect to
sociodemographic characteristics. A third limitation is the potential
lack of generalizability because of over-selection of participants
exposed to maternal GDM. Finally, we cannot discount the potential
for false positive findings given the large number of models. However,
our research focus was to describe and assess the direction, magni-
tude, and precision of the estimates rather than focus on statistical
significance, especially in light of the fact that many of the biomarkers
are correlated markers of the same biological phenomena.
5 | CONCLUSIONS
In this prospective study of approximately 600 multi-ethnic youth, we
extend current literature regarding the relationship between in utero
GDM exposure and cardiovascular health in offspring in two key
aspects. First, we were able to explore the long-term consequences of
maternal GDM on offspring cardiovascular risk factors throughout late
childhood and adolescence via a repeated measures technique. This
approach is not only more efficient from a statistical standpoint but
also lends itself to more robust findings given that the biomarkers of
interest—including total cholesterol and LDL, which we found to differ
by GDM exposure in females—fluctuate across the age range of our
study sample.44 Second, we considered sex-specific associations to
reflect not only biological differences metabolic and cardiovascular
traits as youth progress through the adolescent transition25 but also
potential discrepancies in fetal response to in utero exposures like
maternal glycaemic control.2
While the effect sizes that we detected are modest (approximately
0.35 mmol/L higher total cholesterol and 0.31 mmol/L higher LDL in
girls; approximately 5 mmHg higher SBP in boys for GDM exposed vs
unexposed), they may have important long-term ramifications given
that cardiometabolic risk factors track from childhood/adolescence
into adulthood and are independent predictors of cardiovascular dis-
ease risk.48 For example, in the Bogalusa Heart Study, a 1-mg/dL incre-
ment in LDL (equivalent to an increment of 0.026-mmol/L LDL) at
11 years of age corresponded with nearly two times higher odds of
metabolic syndrome in young adulthood.49 Similarly, a 1-mmHg incre-
ment in childhood SBP predicted elevations in a cluster of metabolic
risk factors in young adulthood including SBP, cholesterol, triglycerides,
and fasting glucose among Bogalusa Heart Study participants.21 Given
the increasing prevalence of GDM in developed countries like the
United States, our findings underscore the importance of efforts to
prevent maternal diabetes in order to improve the health of future
generations.
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